- Home
- INTU vs BSX Comparison
INTU vs BSX Comparison
Compare INTU & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTU
- BSX
- Stock Information
- Founded
- INTU 1983
- BSX 1979
- Country
- INTU United States
- BSX United States
- Employees
- INTU N/A
- BSX N/A
- Industry
- INTU Computer Software: Prepackaged Software
- BSX Medical/Dental Instruments
- Sector
- INTU Technology
- BSX Health Care
- Exchange
- INTU Nasdaq
- BSX Nasdaq
- Market Cap
- INTU 191.8B
- BSX 157.6B
- IPO Year
- INTU 1993
- BSX 1992
- Fundamental
- Price
- INTU $657.64
- BSX $96.09
- Analyst Decision
- INTU Strong Buy
- BSX Strong Buy
- Analyst Count
- INTU 18
- BSX 22
- Target Price
- INTU $812.28
- BSX $121.09
- AVG Volume (30 Days)
- INTU 2.2M
- BSX 12.4M
- Earning Date
- INTU 11-20-2025
- BSX 10-22-2025
- Dividend Yield
- INTU 0.73%
- BSX N/A
- EPS Growth
- INTU 31.06
- BSX 36.90
- EPS
- INTU 13.67
- BSX 1.68
- Revenue
- INTU $18,831,000,000.00
- BSX $18,494,000,000.00
- Revenue This Year
- INTU $14.59
- BSX $19.85
- Revenue Next Year
- INTU $12.50
- BSX $11.07
- P/E Ratio
- INTU $48.13
- BSX $57.07
- Revenue Growth
- INTU 15.63
- BSX 21.44
- 52 Week Low
- INTU $532.65
- BSX $80.64
- 52 Week High
- INTU $813.70
- BSX $109.50
- Technical
- Relative Strength Index (RSI)
- INTU 36.14
- BSX 32.46
- Support Level
- INTU $668.36
- BSX $90.69
- Resistance Level
- INTU $688.36
- BSX $98.48
- Average True Range (ATR)
- INTU 15.36
- BSX 2.43
- MACD
- INTU -0.54
- BSX -0.06
- Stochastic Oscillator
- INTU 6.77
- BSX 55.75
About INTU Intuit Inc.
Intuit serves small and midsize businesses with accounting software QuickBooks and online marketing platform Mailchimp. The company also operates retail tax filing tool TurboTax, personal finance platform Credit Karma, and a suite of professional tax offerings for accountants. Founded in the mid-1980s, Intuit enjoys a dominant market share for small-to-midsize business accounting and self-serve tax filing in the US.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.